Want to see KR:063160 full AI Analyst Report?
CKD Bio Corp. (063160) Income Statement
CKD Bio Corp. Income Statement
Last quarter (Q2 2026), CKD Bio Corp.'s total revenue was $41.09B, a decrease of 0.30% from the same quarter last year. In Q2, CKD Bio Corp.'s net income was $-5.41B. See CKD Bio Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 160.07B | $ 171.76B | $ 160.35B | $ 156.04B | $ 142.24B | |
| $ 26.10B | $ 35.94B | $ 5.01B | $ 16.79B | $ 13.31B | |
| $ 22.50B | $ 24.99B | $ 25.20B | $ 31.60B | $ 24.74B | |
| Depreciation and Amortization | $ 15.65B | $ 16.69B | $ 17.58B | $ 17.94B | $ 16.98B |
| $ 19.26B | $ 31.17B | $ -1.63B | $ 2.29B | $ 5.56B | |
| $ 3.61B | $ 10.95B | $ -20.15B | $ -14.77B | $ -9.81B | |
| $ -6.57B | $ -1.74B | $ -4.04B | $ -3.78B | $ -2.56B | |
| $ -2.97B | $ 9.22B | $ -24.20B | $ -18.59B | $ -13.36B | |
| $ -2.89B | $ 8.70B | $ -24.19B | $ -16.70B | $ -6.58B | |
| Per Share Metrics | |||||
| Basic EPS | $ -526.16 | $ 1586.02 | $ -4409.90 | $ -3044.61 | $ -1198.81 |
| Diluted EPS | $ -526.16 | $ 1586.02 | $ -4409.90 | $ -3044.61 | $ -1198.81 |
| Weighted Average Shares Outstanding | 5.49M | 5.49M | 5.49M | 5.49M | 5.49M |
| Weighted Average Shares Outstanding (Diluted) | 5.49M | 5.49M | 5.49M | 5.49M | 5.49M |
Currency in KRW
